Bernstein analyst Sabrina Blanc initiated coverage of Elis with an Outperform rating and EUR 26.60 price target. The analyst expects “robust” revenue growth in 2024 driven by a mix of price effect and volumes. With the company’s churn likely to normalize in 2025, 4% annual organic sales growth is sustainable thereafter, the analyst tells investors in a research note.